Friday, April 18, 2025

ICU-Acquired Weakness

 

ICU-Acquired Weakness: Diagnosis, Prevention, and Rehabilitation

Dr Neeraj Manikath ,claude.ai

Abstract

Intensive care unit-acquired weakness (ICUAW) is a common complication in critically ill patients, characterized by symmetric muscle weakness affecting the limbs and respiratory muscles. This condition significantly impacts patient outcomes, including prolonged mechanical ventilation, extended ICU and hospital stays, increased healthcare costs, and higher mortality rates. This review aims to provide a comprehensive analysis of the current understanding of ICUAW with a focus on diagnostic approaches, preventive strategies, and rehabilitation techniques. Special emphasis is placed on early mobilization protocols, physiotherapy interventions, neuromuscular monitoring, and electrical muscle stimulation. Through this analysis, we highlight evidence-based practices to guide clinicians in mitigating the impact of ICUAW and improving patient outcomes.

Keywords: ICU-acquired weakness, critical illness polyneuropathy, critical illness myopathy, early mobilization, electrical muscle stimulation, rehabilitation

Introduction

ICU-acquired weakness (ICUAW) represents a significant complication affecting up to 40-60% of critically ill patients, with even higher prevalence rates in those with sepsis, multi-organ failure, or prolonged mechanical ventilation[1,2]. ICUAW encompasses several distinct but overlapping conditions: critical illness polyneuropathy (CIP), critical illness myopathy (CIM), and critical illness neuromyopathy (CINM), all characterized by generalized muscle weakness developing during an ICU stay without an alternative explanation[3].

The pathophysiology of ICUAW involves complex interactions between inflammatory mediators, metabolic derangements, medication effects (particularly corticosteroids and neuromuscular blocking agents), immobility, and microcirculatory alterations[4]. These factors contribute to muscle proteolysis, axonal degeneration, and altered neuromuscular transmission, resulting in the clinical presentation of symmetric weakness predominantly affecting the limbs and respiratory muscles[5].

The consequences of ICUAW extend well beyond the acute phase of critical illness. Patients experience difficulty weaning from mechanical ventilation, prolonged rehabilitation requirements, and persistent functional limitations that may continue for months or years after discharge[6,7]. Given these profound impacts, early diagnosis, prevention, and targeted rehabilitation strategies have become essential components of comprehensive critical care.

Diagnosis of ICU-Acquired Weakness

Clinical Assessment

The diagnosis of ICUAW primarily relies on clinical examination, with the Medical Research Council (MRC) sum score being the most widely used assessment tool[8]. The MRC sum score evaluates muscle strength in six muscle groups bilaterally (shoulder abduction, elbow flexion, wrist extension, hip flexion, knee extension, and ankle dorsiflexion) on a scale from 0 (no contraction) to 5 (normal strength). A total score below 48 out of 60 is considered diagnostic for ICUAW[9].

Clinical evaluation faces several challenges in the ICU setting:

  • Patient cooperation may be limited due to sedation, delirium, or cognitive impairment
  • Pain and underlying critical illness may interfere with accurate strength assessment
  • Timing of assessment varies across studies, complicating standardization efforts

Hand-held dynamometry offers a more objective strength measurement, particularly for handgrip strength, which correlates well with overall muscle strength and functional outcomes[10].

Electrophysiological Studies

Electrophysiological studies can differentiate between the various forms of ICUAW and provide insights into the severity and progression of neuromuscular dysfunction:

  1. Nerve Conduction Studies (NCS): Demonstrate reduced compound muscle action potential (CMAP) amplitudes with normal or mildly reduced nerve conduction velocities in CIP, while sensory nerve action potentials (SNAPs) are typically diminished[11].

  2. Electromyography (EMG): Reveals fibrillation potentials and positive sharp waves, suggestive of active denervation in CIP. In CIM, short-duration, low-amplitude motor unit potentials may be observed[12].

  3. Direct Muscle Stimulation: The ratio of direct muscle stimulation to nerve stimulation can help differentiate CIM from CIP, with preserved ratios in CIP and reduced ratios in CIM[13].

Although electrophysiological studies provide valuable diagnostic information, their routine use is limited by practical constraints, including technical difficulties in performing studies in the ICU environment, patient discomfort, and the need for specialized expertise for interpretation[14].

Biomarkers

Several biomarkers have been investigated for the early detection of ICUAW:

  • Creatine Kinase (CK): Although elevated in various muscle disorders, CK levels show poor sensitivity for ICUAW diagnosis[15].
  • Neurofilament Light Chain (NFL): A marker of axonal injury that shows promise for early CIP detection[16].
  • Inflammatory Markers: IL-6, TNF-α, and C-reactive protein correlate with ICUAW development, reflecting the role of inflammation in its pathogenesis[17].

These biomarkers currently lack sufficient specificity and sensitivity for routine clinical use but represent an active area of research for early ICUAW detection.

Imaging Techniques

Advanced imaging modalities offer non-invasive assessment of neuromuscular changes:

  • Ultrasound: Serial measurements of muscle thickness and echogenicity can detect early muscle wasting and compositional changes. Decreases in quadriceps muscle thickness of >10% within the first week of ICU admission are associated with ICUAW development[18,19].
  • Magnetic Resonance Imaging (MRI): Provides detailed visualization of muscle architecture and can detect myonecrosis and fatty infiltration, although its use is limited by practical constraints in critically ill patients[20].

Muscle Biopsy

Muscle biopsy remains the gold standard for differentiating between CIM and CIP, revealing characteristic histopathological features:

  • CIM: Type II fiber atrophy, thick filament loss, and myosin depletion
  • CIP: Denervation atrophy with angular fibers and fiber-type grouping

However, the invasive nature of this procedure limits its routine clinical application[21].

Prevention Strategies

Risk Factor Modification

Effective prevention begins with identifying and addressing modifiable risk factors:

  1. Glycemic Control: Maintaining blood glucose levels between 140-180 mg/dL appears to strike an optimal balance between preventing hyperglycemia-associated neuropathy and avoiding hypoglycemia complications[22,23].

  2. Minimizing Sedation: Implementing daily sedation interruption protocols and targeting light sedation levels reduces immobility and facilitates earlier participation in rehabilitation[24].

  3. Judicious Use of Medications: Limiting exposure to corticosteroids and neuromuscular blocking agents to the shortest necessary duration and lowest effective doses may mitigate their contribution to ICUAW[25,26].

  4. Nutritional Support: Early enteral nutrition with adequate protein provision (1.5-2.0 g/kg/day) supports muscle protein synthesis and may attenuate muscle catabolism[27,28].

Early Mobilization

Early mobilization has emerged as a cornerstone in ICUAW prevention. Progressive mobility protocols typically follow a hierarchical approach:

  1. Passive Range of Motion (PROM): For patients unable to participate actively
  2. In-bed Exercises: Including active range of motion and bed cycling
  3. Sitting Position: Progressing from supported to unsupported sitting
  4. Standing and Transfer Training: With appropriate assistive devices
  5. Walking: Beginning with assistance and progressing to independent ambulation

The AVERT trial demonstrated that early mobilization (within 24 hours of ICU admission) is feasible and safe in appropriately selected patients[29]. The landmark SOMS (Surgical Optimal Mobilization Score) study showed that structured progressive mobility protocols reduced ICU and hospital length of stay while improving functional outcomes at discharge[30].

Implementation considerations include:

  • Early initiation, ideally within 24-48 hours of ICU admission when hemodynamically stable
  • Multidisciplinary approach involving physicians, nurses, physical therapists, and respiratory therapists
  • Standardized protocols with clear safety criteria for progression
  • Regular reassessment and protocol adjustment based on patient tolerance and progress

Barriers to early mobilization include concerns about patient safety, limited resources, inadequate training, and organizational culture. Successful implementation strategies incorporate staff education, protocol development, interdisciplinary collaboration, and administrative support[31].

Physiotherapy Interventions

Comprehensive physiotherapy for ICUAW prevention extends beyond mobilization to include:

  1. Respiratory Physiotherapy: Techniques such as manual hyperinflation, positioning, and active cycle of breathing techniques can improve secretion clearance and lung recruitment, potentially reducing ventilator dependence[32].

  2. Inspiratory Muscle Training: Progressive resistance training for respiratory muscles may enhance weaning outcomes in selected patients, though evidence remains inconsistent[33].

  3. Cycle Ergometry: Bedside ergometers allow passive or active cycling exercises for lower extremities, preserving muscle mass and function during critical illness. The CYCLE study demonstrated improved six-minute walk test distances at hospital discharge in patients receiving in-bed cycling interventions[34].

  4. Functional Electrical Stimulation (FES): Combining electrical stimulation with voluntary muscle contraction during cycling exercises may provide enhanced benefits compared to either intervention alone[35].

Neuromuscular Monitoring

Proactive neuromuscular monitoring facilitates early detection of ICUAW and guides prevention strategies:

  1. Train-of-Four (TOF) Monitoring: Essential when neuromuscular blocking agents are administered, ensuring appropriate dosing and recovery of neuromuscular function[36].

  2. Serial Clinical Strength Assessments: Regular evaluation using the MRC sum score or dynamometry helps identify strength changes requiring intervention[37].

  3. Electrophysiological Monitoring: Serial nerve conduction studies and electromyography in high-risk patients may detect subclinical neuromuscular dysfunction before clinical weakness manifests[38].

  4. Ultrasound Surveillance: Regular monitoring of muscle thickness and echogenicity can track the trajectory of muscle changes and guide nutritional and rehabilitation interventions[39].

Implementing systematic monitoring protocols increases awareness of ICUAW and provides opportunities for early intervention, particularly in high-risk populations such as patients with sepsis or multi-organ failure[40].

Electrical Muscle Stimulation

Electrical muscle stimulation (EMS) represents a promising modality for ICUAW prevention and treatment, particularly when patients cannot actively participate in exercise. EMS delivers controlled electrical impulses to skeletal muscles through surface electrodes, generating muscle contractions that mimic voluntary exercise.

Mechanism of Action

EMS produces several physiological effects relevant to ICUAW:

  • Increases muscle blood flow and microcirculation
  • Preserves muscle mass by activating anabolic signaling pathways
  • Maintains muscle contractile properties
  • Reduces inflammatory cytokine production
  • Improves glucose metabolism and insulin sensitivity[41,42]

Clinical Evidence

Several randomized controlled trials have investigated EMS in critically ill patients:

  1. The EMSCI Study: Applied daily EMS to quadriceps and hamstrings in septic patients, demonstrating preservation of muscle mass measured by ultrasound and reduced development of ICUAW compared to standard care (relative risk reduction of 35%)[43].

  2. Routsi et al.: Found that daily EMS application to lower extremities reduced the incidence of ICUAW (odds ratio 0.22) and resulted in shorter weaning periods compared to controls[44].

  3. Gerovasili et al.: Demonstrated significantly less muscle mass loss in the EMS group using ultrasound measurements of cross-sectional diameter in critically ill patients[45].

A meta-analysis by Burke et al. including 15 trials with 805 participants found that EMS was associated with greater muscle strength at ICU discharge (standardized mean difference 0.77) and shorter duration of mechanical ventilation (mean difference -1.06 days)[46].

Implementation Considerations

Optimal EMS protocols remain under investigation, but current evidence supports:

  1. Stimulation Parameters:

    • Frequency: 35-100 Hz
    • Pulse duration: 300-400 μs
    • On-off cycle: 5-10 seconds on, 10-20 seconds off
    • Duration: 30-60 minutes per session
    • Frequency: 1-2 sessions daily

  2. Muscle Groups: Priority targets include the quadriceps, hamstrings, tibialis anterior, and gastrocnemius muscles, with some protocols also incorporating upper extremity muscles.

  3. Timing: Early initiation within 24-48 hours of ICU admission appears beneficial.

  4. Contraindications: Local skin breakdown, presence of implanted electronic devices (relative contraindication), severe peripheral vascular disease, and seizure disorders require careful consideration.

  5. Patient Selection: Patients unable to participate in active mobilization and those at high risk for ICUAW (e.g., sepsis, multi-organ failure) may derive the greatest benefit[47].

Despite promising results, EMS cannot fully replace active exercise when possible, and optimal integration with comprehensive rehabilitation programs requires further investigation.

Rehabilitation Approaches

ICU-Based Rehabilitation

Structured rehabilitation in the ICU environment focuses on:

  1. Task-Specific Training: Practicing functional activities relevant to daily living, such as bed mobility, transfers, and self-care tasks, even while patients remain on life support[48].

  2. Progressive Resistance Training: Incorporating resistance bands, small weights, or manual resistance when appropriate to preserve muscle strength and stimulate protein synthesis[49].

  3. Neuromuscular Electrical Stimulation (NMES): Applied therapeutically to target specific muscle groups with weakness, often combined with active exercises when possible[50].

  4. Virtual Reality and Gamification: Novel approaches incorporating technology to increase engagement and motivation during rehabilitation sessions have shown promise in pilot studies[51].

The TEAM randomized trial demonstrated that tailored early activity and mobility programs guided by physical therapists improved physical function scores and reduced delirium incidence compared to usual care[52].

Post-ICU Rehabilitation

Recovery from ICUAW often extends well beyond the ICU stay, necessitating structured post-ICU rehabilitation:

  1. Inpatient Rehabilitation: Continued daily therapy focusing on progressive strengthening, endurance training, and functional mobility in the ward setting.

  2. Outpatient Programs: Specialized ICU follow-up clinics providing multidisciplinary care addressing physical, cognitive, and psychological sequelae of critical illness.

  3. Home-Based Rehabilitation: Structured home exercise programs with periodic professional supervision have shown efficacy in improving long-term functional outcomes[53].

  4. Telerehabilitation: Remote supervision of rehabilitation programs via digital platforms offers promise for extending specialized rehabilitation services, particularly for patients with geographical barriers to center-based care[54].

The RECOVER program demonstrated that nurse-led, case-managed rehabilitation programs spanning the continuum from ICU to community improved quality of life and functional status at 12 months compared to standard care[55].

Special Considerations

  1. Respiratory Muscle Rehabilitation: Specific attention to inspiratory and expiratory muscle training can improve respiratory function and facilitate ventilator weaning in patients with respiratory muscle weakness[56].

  2. Dysphagia Management: ICUAW frequently affects bulbar muscles, necessitating formal swallowing evaluation and targeted rehabilitation to prevent aspiration and malnutrition[57].

  3. Pain Management: Adequate analgesia is essential to enable effective participation in rehabilitation while minimizing opioid exposure[58].

  4. Psychological Support: Addressing anxiety, depression, and post-traumatic stress, which frequently co-occur with ICUAW and can impede physical recovery[59].

  5. Nutritional Rehabilitation: Ongoing nutritional optimization, particularly protein supplementation coordinated with exercise sessions to maximize anabolic response[60].

Conclusion

ICU-acquired weakness represents a significant challenge in critical care medicine with profound implications for short and long-term patient outcomes. Early diagnosis through clinical assessment, electrophysiological studies, biomarkers, and imaging techniques allows prompt intervention. Prevention strategies focusing on risk factor modification, early mobilization, comprehensive physiotherapy, and neuromuscular monitoring can significantly reduce ICUAW incidence and severity.

Electrical muscle stimulation offers a promising adjunctive therapy, particularly for patients unable to participate in active exercise. Structured rehabilitation approaches spanning the continuum from ICU to community are essential for optimizing recovery trajectories.

Future research directions should focus on personalizing prevention and rehabilitation strategies based on individual risk profiles, developing novel biomarkers for early detection, optimizing EMS protocols, and investigating combination therapies to enhance neuromuscular recovery. Additionally, implementation science approaches are needed to translate evidence-based interventions into routine clinical practice across diverse healthcare settings.

Through continued advances in understanding, prevention, and management of ICUAW, the critical care community can significantly improve the functional outcomes and quality of life for survivors of critical illness.

References

  1. Hermans G, Van den Berghe G. Clinical review: intensive care unit acquired weakness. Crit Care. 2015;19(1):274.

  2. Jolley SE, Bunnell AE, Hough CL. ICU-Acquired Weakness. Chest. 2016;150(5):1129-1140.

  3. Stevens RD, Marshall SA, Cornblath DR, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med. 2009;37(10 Suppl):S299-S308.

  4. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011;10(10):931-941.

  5. Piva S, Fagoni N, Latronico N. Intensive care unit-acquired weakness: unanswered questions and targets for future research. F1000Res. 2019;8:F1000 Faculty Rev-508.

  6. Herridge MS, Tansey CM, Matté A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364(14):1293-1304.

  7. Needham DM, Davidson J, Cohen H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Crit Care Med. 2012;40(2):502-509.

  8. Fan E, Cheek F, Chlan L, et al. An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med. 2014;190(12):1437-1446.

  9. De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288(22):2859-2867.

  10. Ali NA, O'Brien JM Jr, Hoffmann SP, et al. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med. 2008;178(3):261-268.

  11. Latronico N, Nattino G, Guarneri B, et al. Validation of the peroneal nerve test to diagnose critical illness polyneuropathy and myopathy in the intensive care unit: the multicentre Italian CRIMYNE-2 diagnostic accuracy study. F1000Res. 2014;3:127.

  12. Lacomis D. Electrophysiology of neuromuscular disorders in critical illness. Muscle Nerve. 2013;47(3):452-463.

  13. Rich MM, Teener JW, Raps EC, Schotland DL, Bird SJ. Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology. 1996;46(3):731-736.

  14. Latronico N, Gosselink R. A guided approach to diagnose severe muscle weakness in the intensive care unit. Rev Bras Ter Intensiva. 2015;27(3):199-201.

  15. Witteveen E, Wieske L, van der Poll T, et al. Increased Early Systemic Inflammation in ICU-Acquired Weakness; A Prospective Observational Cohort Study. Crit Care Med. 2017;45(6):972-979.

  16. Wieske L, Dittrich E, Verhamme C, et al. Neurofilament light chain as a biomarker in critical illness polyneuropathy and myopathy. Neurology. 2021;96(22):e2733-e2743.

  17. Friedrich O, Reid MB, Van den Berghe G, et al. The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill. Physiol Rev. 2015;95(3):1025-1109.

  18. Puthucheary ZA, Rawal J, McPhail M, et al. Acute skeletal muscle wasting in critical illness. JAMA. 2013;310(15):1591-1600.

  19. Mourtzakis M, Parry S, Connolly B, Puthucheary Z. Skeletal Muscle Ultrasound in Critical Care: A Tool in Need of Translation. Ann Am Thorac Soc. 2017;14(10):1495-1503.

  20. Connolly B, MacBean V, Crowley C, et al. Ultrasound for the assessment of peripheral skeletal muscle architecture in critical illness: a systematic review. Crit Care Med. 2015;43(4):897-905.

  21. Puthucheary Z, Harridge S, Hart N. Skeletal muscle dysfunction in critical care: wasting, weakness, and rehabilitation strategies. Crit Care Med. 2010;38(10 Suppl):S676-S682.

  22. NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-1297.

  23. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-1367.

  24. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342(20):1471-1477.

  25. De Jonghe B, Sharshar T, Lefaucheur JP, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002;288(22):2859-2867.

  26. Jung B, Moury PH, Mahul M, et al. Diaphragmatic dysfunction in patients with ICU-acquired weakness and its impact on extubation failure. Intensive Care Med. 2016;42(5):853-861.

  27. Heyland DK, Stapleton RD, Mourtzakis M, et al. Combining nutrition and exercise to optimize survival and recovery from critical illness: Conceptual and methodological issues. Clin Nutr. 2016;35(5):1196-1206.

  28. Bear DE, Wandrag L, Merriweather JL, et al. The role of nutritional support in the physical and functional recovery of critically ill patients: a narrative review. Crit Care. 2017;21(1):226.

  29. AVERT Trial Collaboration group. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet. 2015;386(9988):46-55.

  30. Schaller SJ, Anstey M, Blobner M, et al. Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trial. Lancet. 2016;388(10052):1377-1388.

  31. Dubb R, Nydahl P, Hermes C, et al. Barriers and Strategies for Early Mobilization of Patients in Intensive Care Units. Ann Am Thorac Soc. 2016;13(5):724-730.

  32. Gosselink R, Bott J, Johnson M, et al. Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill Patients. Intensive Care Med. 2008;34(7):1188-1199.

  33. Vorona S, Sabatini U, Al-Maqbali S, et al. Inspiratory Muscle Rehabilitation in Critically Ill Adults: A Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2018;15(6):735-744.

  34. Kho ME, Molloy AJ, Clarke FJ, et al. Multicentre pilot randomised clinical trial of early in-bed cycle ergometry with ventilated patients. BMJ Open Respir Res. 2019;6(1):e000383.

  35. Parry SM, Berney S, Warrillow S, et al. Functional electrical stimulation with cycling in the critically ill: A pilot case-matched control study. J Crit Care. 2014;29(4):695.e1-7.

  36. Rudis MI, Sikora CA, Angus E, et al. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med. 1997;25(4):575-583.

  37. Hermans G, Clerckx B, Vanhullebusch T, et al. Interobserver agreement of Medical Research Council sum-score and handgrip strength in the intensive care unit. Muscle Nerve. 2012;45(1):18-25.

  38. Latronico N, Nattino G, Guarneri B, et al. Validation of the peroneal nerve test to diagnose critical illness polyneuropathy and myopathy in the intensive care unit: the multicentre Italian CRIMYNE-2 diagnostic accuracy study. F1000Res. 2014;3:127.

  39. Parry SM, El-Ansary D, Cartwright MS, et al. Ultrasonography in the intensive care setting can be used to detect changes in the quality and quantity of muscle and is related to muscle strength and function. J Crit Care. 2015;30(5):1151.e9-14.

  40. Witteveen E, Sommers J, Wieske L, et al. Diagnostic accuracy of quantitative neuromuscular ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-sectional observational study. Ann Intensive Care. 2017;7(1):40.

  41. Maffiuletti NA, Roig M, Karatzanos E, Nanas S. Neuromuscular electrical stimulation for preventing skeletal-muscle weakness and wasting in critically ill patients: a systematic review. BMC Med. 2013;11:137.

  42. Dirks ML, Hansen D, Van Assche A, Dendale P, Van Loon LJ. Neuromuscular electrical stimulation prevents muscle wasting in critically ill comatose patients. Clin Sci (Lond). 2015;128(6):357-365.

  43. Kho ME, Truong AD, Zanni JM, et al. Neuromuscular electrical stimulation in mechanically ventilated patients: a randomized, sham-controlled pilot trial with blinded outcome assessment. J Crit Care. 2015;30(1):32-39.

  44. Routsi C, Gerovasili V, Vasileiadis I, et al. Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial. Crit Care. 2010;14(2):R74.

  45. Gerovasili V, Stefanidis K, Vitzilaios K, et al. Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study. Crit Care. 2009;13(5):R161.

  46. Burke D, Gorman E, Stokes D, Lennon O. An evaluation of neuromuscular electrical stimulation in critical care using the ICF framework: a systematic review and meta-analysis. Clin Respir J. 2016;10(4):407-420.

  47. Parry SM, Berney S, Koopman R, et al. Early rehabilitation in critical care (eRiCC): functional electrical stimulation with cycling protocol for a randomised controlled trial. BMJ Open. 2012;2(5):e001891.

  48. Morris PE, Berry MJ, Files DC, et al. Standardized Rehabilitation and Hospital Length of Stay Among Patients With Acute Respiratory Failure: A Randomized Clinical Trial. JAMA. 2016;315(24):2694-2702.

  49. Burtin C, Clerckx B, Robbeets C, et al. Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med. 2009;37(9):2499-2505.

  50. Fossat G, Baudin F, Courtes L, et al. Effect of In-Bed Leg Cycling and Electrical Stimulation of the Quadriceps on Global Muscle Strength in Critically Ill Adults: A Randomized Clinical Trial. JAMA. 2018;320(4):368-378.

  51. Kho ME, Damluji A, Zanni JM, Needham DM. Feasibility and observed safety of interactive video games for physical rehabilitation in the intensive care unit: a case series. J Crit Care. 2012;27(2):219.e1-6.

  52. Tipping CJ, Harrold M, Holland A, et al. The effects of active mobilisation and rehabilitation in ICU on mortality and function: a systematic review. Intensive Care Med. 2017;43(2):171-183.

  53. Elliott D, McKinley S, Alison J, et al. Health-related quality of life and physical recovery after a critical illness: a multi-centre randomised controlled trial of a home-based physical rehabilitation program. Crit Care. 2011;15(3):R142.

  54. Pinto RZ, Ferreira ML, Oliveira VC, et al. Patient-centred communication is associated with positive therapeutic alliance: a systematic review. J Physiother. 2012;58(2):77-87.

  55. Walsh TS, Salisbury LG, Merriweather JL, et al. Increased Hospital-Based Physical Rehabilitation and Information Provision After Intensive Care Unit Discharge: The RECOVER Randomized Clinical Trial. JAMA Intern Med. 2015;175(6):901-910.

  56. Martin AD, Smith BK, Davenport PD, et al. Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial. Crit Care. 2011;15(2):R84.

  57. Macht M, Wimbish T, Clark BJ, et al. Postextubation dysphagia is persistent and associated with poor outcomes in survivors of critical illness. Crit Care. 2011;15(5):R231.

  58. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263-306.

  59. Jackson JC, Pandharipande PP, Girard TD, et al. Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study. Lancet Respir Med. 2014;2(5):369-379.

  60. Bear DE, Wandrag L, Merriweather JL, et al. The role of nutritional support in the physical and functional recovery of critically ill patients: a narrative review. Crit Care. 2017;21(1):226.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)